Bayer Ag (adr) Stock News

Coherent Market Insights published a business research report on Androgen Replacement Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022-2028. Androgen Replacement Therapy Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages

Bayer (BAYZF) is raising peak sales expectation for Nubeqa (darolutamide) after the drug, in combination with other therapies, increased overall survival ((OS)) in patients with…

Bayer said a therapy mix including its Nubeqa drug was shown to significantly prolong the lives of men suffering from metastatic prostate cancer in a clinical study, underpinning prospects for the drug to become a major sales driver. The post Bayer’s Nubeqa drug significantly prolongs survival in prostate cancer trial appeared first on SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa''s news leader. .

© Reuters. By Karl Plume (Reuters) – Global farm chemicals and seeds maker Bayer (OTC:) will launch a corn variety in the United States next year that it says will better tolerate heavy winds associated with climate change, estimating future sales in North America as high as 1 billion euros. The corn, which grows one-third …

https://www.investing.com/news/stock-market-news/bayer-rolls-out-short-corn-variety-tolerant-of-weather-extremes-2766579

By Ana Mano SAO PAULO (Reuters) – A unit of Norwegian plant nutrition company Yara International ASA has acquired for an undisclosed sum a 14% stake in Brazilian online farm products trade platform Orbia, majority owned by Germany’s Bayer AG.

Organon (OGN) announced on Wednesday that the company acquired the rights for Marvelon and Mercilon combined oral hormonal daily contraceptive pills in China (including Hong Kong and…

A2Z Market Research published new research on Global Pet Speciality Drugs covering micro level of analysis by competitors and key business segments (2022-2029). The Global Pet Speciality Drugs explores comprehensive study on various segments like opportunities, size, development, innovation, sales

Aveo Pharmaceuticals Inc (NASDAQ: AVEO ) will present new long-term progression-free survival (PFS) data from the Phase 3 TIVO-3 study in kidney cancer at the 2022 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium. The trial is evaluating Fotivda (tivozanib) to Bayer AG''s (OTC: BAYRY ) … Full story available on Benzinga.com

Bayer <> said it declared force majeure over supply chain issues on the manufacture of glyphosate products in the U.S., as a supplier of a raw ingredient needed

FRANKFURT (Reuters) – Pesticides and seeds maker Bayer said on Monday a supplier of an ingredient for its widely used herbicide glyphosate ran into technical problems which may hamper Bayer’s glyphosate production in the short term.

Demand for fresh water is outrunning supply as the result of aquifer and reservoir depletion; farmers are having to cut back. At the same time, crops are coming under stress as the result of climate c

US-based Monsanto, which was taken over by Bayer in 2018, had withdrawn its application seeking approval for its next generation GM seeds in 2016, following a dispute between New Delhi and the world''s biggest seed maker.

It might take a few years for Bayer to get the final approval

In late 2016, Monsanto withdrew an application seeking approval from New Delhi for the GM variety Bollgard II Roundup Ready Flex (RRF)